Regulatory Open Forum

 View Only
Expand all | Collapse all

Tips for ISO 13485:2016 transition

  • 1.  Tips for ISO 13485:2016 transition

    This message was posted by a user wishing to remain anonymous
    Posted 13-Oct-2017 09:37
    This message was posted by a user wishing to remain anonymous

    Hi RAPS forum,

    For those of you who have completed or are in the process of completing their ISO 13485:2016 transition/implementation:

    • What are your lessons learned?
    • Which tricky items did the Notified Body ask you about? Did you disagree or have any surprises during the audit? 
    • Did they provide you any tool/checklist prior to the audit? If so, are you willing to share?
    • What were your biggest hurdles in implementing the ISO 13485:2016 ? Which solutions did you find to overcome them? Can you provide some practical examples?
    • What helped you in a practical way to transition/implement ISO 13485:2016 ?

    Thank you very much in advance for sharing your experience/examples/tools/checklists.



  • 2.  RE: Tips for ISO 13485:2016 transition

    Posted 14-Oct-2017 07:20
    There is a new publication that might help. ISO has released the ISO Handbook which has lots of helpful information on implementation.

    ------------------------------
    Edwin Bills RAC, MA
    Principal Consultant
    Edwin Bills Consultant
    Overland Park KS
    United States
    ------------------------------



  • 3.  RE: Tips for ISO 13485:2016 transition

    Posted 14-Oct-2017 11:39
    As the co-lead for the project, we hope you find the handbook useful. Please find it here from AAMI:

    http://my.aami.org/store/detail.aspx?id=13485-ISO-PDF

    <u5:p></u5:p>

    ------------------------------
    Regards,
    Mark Swanson, ASQ CBA, CMQ/OE, CQE MBA
    Becker MN
    United States
    ------------------------------



  • 4.  RE: Tips for ISO 13485:2016 transition

    Posted 15-Oct-2017 14:55

    This "Practical Guide" is helpful for understanding the basis for ISO 13485:2016 requirements and getting clues to ensure conformity.

    It costs only 88 CHF (about USD 90) if purchased directly from ISO (no affiliation) and It includes the full content of the standard itself, together with Intent and Guidance information.

    Some people (including me) have been confused about Medical Device File (MDF) requirements per clause 4.2.3. I think this is because the contents listing (4.2.3.a through f) appears to be more narrow than what the first sentence of 4.2.3 specifies. 

    At first glance (especially if you skip over the first sentence), the contents listing (4.2.3.a through f) appears to be equivalent to what FDA calls the "Device Master Record" (DMR). This interpretation is supported by the fact that device Instructions For Use (IFU) typically include a general description of the device and <g class="gr_ gr_1218 gr-alert gr_spell gr_inline_cards gr_disable_anim_appear ContextualSpelling multiReplace" id="1218" data-gr-id="1218">its</g> intended use as required per 4.2.3.a.

    However, the first sentence of clause 4.2.3 indicates that the MDF contains/references all documents needed to show conformity and compliance with ISO 13485 and regulatory requirements, respectively. That is very broad indeed!

    This has become such a broad concept that it leads me to believe that all QMS documents (including records) are what comprises the MDF.
    From my perspective, all of the QMS documents combined are needed to demonstrate conformity with ISO 13485 and compliance with regulatory requirements (what the first sentence of 4.2.3 requires).

    Can anybody add anything to help clarify the derivation and meaning of the MDF requirements?

     



    ------------------------------
    Sam Lazzara
    http://mdqc.com
    ------------------------------



  • 5.  RE: Tips for ISO 13485:2016 transition

    Posted 16-Oct-2017 07:55
    Hi Sam,

    You are on track that is similar to the Device Master Record (the recipe for your medical device). The first statement is not intended to be as wide as you are trying to interpret, but rather it is aligned with the Medical Device Regulation (EU MDR) as well to ensure the appropriate regulatory requirements are met with regard to technical documentation. Hope that helps!


    ------------------------------
    Kind Regards,
    Mark Swanson, ASQ CBA, CMQ/OE, CQE MBA
    Becker MN
    United States
    ------------------------------



  • 6.  RE: Tips for ISO 13485:2016 transition

    Posted 17-Oct-2017 10:44

    QSR has two concepts that are relevant here. One is a file of device specific information, the Device Master Record (DMR) in §820.181. The other, the Quality System Record (QSR) in §820.186, is a file of information that is not specific to a particular type of device, including, but not limited to, the records required by §820.20.

     

    The QSR preamble has an interesting discussion of why FDA created the §820.186 QSR.

     

    Every device manufacturer not exempt from Part 820 must have a Quality System Record. There is an interesting Warning Letter to X-Ray Support, Inc. dated September 23, 2011 citing them for failure to have a Quality System Record. It says, "Upon request by the investigator for the above referenced procedures, you indicated the requested procedures were located in your head."

     

    ISO 13485:2016 includes a file that is analogous to the DMR, the Medical Device File (MDF) in Clause 4.2.3. It doesn't have an analog to the QSR's QSR.

     

    ISO 13485:2016 introduces two concepts for QMS requirements. In one, requirements come for the clauses of ISO 13485:2016. In the other, requirements come from the regional or national regulations in which the company provides products. In Clause 4.1.1 the company must identify its roles in each regulatory region, determine the applicable regulatory requirements for that role, and include them in the QMS. One role of particular interest is manufacturer.

     

    The MDF is device type or family specific. It doesn't include QMS requirements that are not device specific. For example, it would not include information about management review because that is not device specific. However, it would include information about a validated production process used in manufacturing the device under 4.2.3.c.

     

    The MDF is a meld of the two sources of requirements. For example, EN ISO 13485:2016 Annex ZB, Table ZB.1 points out that MDD Annex II Clause 3.2, 3rd paragraph (e) requires documentation of the "appropriate tests and trials which will be carried out before, during, and after manufacture, the frequency with which they will take place, and the test equipment used; it must be possible to trace back the calibration of the test equipment adequately".

     

    This is a regulatory requirement from the EU, through the MDD. If you put the CE Mark on your device using Annex II, then you must implement it. Consequently, it would show up as part of measuring and monitoring under 4.2.3.d.

     

    In summary, the MDF is device specific and includes both ISO 13485:2016 requirements and any regulatory requirements in the company's role as a manufacturer. I recommend that companies review the MDSAP audit document for device specific requirements in those regulatory regions.



    ------------------------------
    Dan O'Leary
    Swanzey NH
    United States
    ------------------------------



  • 7.  RE: Tips for ISO 13485:2016 transition

    Posted 15-Oct-2017 17:42
    Greenlight.guru has a free guide and audit checklist.  Can be found here:

    http://www.medicaldevicesgroup.net/wp-content/uploads/How-to-Simplify-Compliance-with-the-New-ISO-13485-2016-Final.pdf

    ISO 13485:2016 Compliance Webinar Exclusive Offer - Free QMS Audit Checklist

    Regards,


    ------------------------------
    John Minier, RAC
    Consultant, Principal
    Minier Medical Device Consulting
    john@johnminier.com
    1(914)850-4432
    Highland Mills, NY
    United States
    ------------------------------



  • 8.  RE: Tips for ISO 13485:2016 transition

    Posted 16-Oct-2017 12:27

    We successfully passed our "upgrade audit" early September 2017.

    I've written a few things about this issue in a related Forum thread ("Cost of transition to ISO 13485:2016")  (https://connect.raps.org/communities/community-home/digestviewer/viewthread?GroupId=97&MessageKey=adc850d2-66fc-491d-8561-43bf0165dd45&CommunityKey=5af348a7-851e-4594-b467-d4d0983b6d89&tab=digestviewer ).

    Yet, see our below answer to the issues raised in your five bullet points. Beware that we are based in Europe and that we are a medium sized research and development oriented company (i.e., not a large multi-site manufacturing and marketing/sales oriented company). For almost all our certification needs, we have been working for over 25 years with one of the leading Notified Bodies (TüV SüD Product Service of Munich, Germany).

    1.  Major lessons learned

    (a) we have always made significant efforts to pro-actively keep our QMS up-to-date and we've always aimed at compliance with both European and USA regulations (including 21 CFR 820). So, subjects for which norms were first published or revised after the publication of ISO 13485:2003 were already firmly in place at the time of transitioning to the 2016-revision (e.g., software life cycle, usability, devices for home use, and risk management). Likewise for subjects that were known to receive a lot of attention from FDA, but much less from European regulators, and that are now finally implemented in ISO 13485:2016 (e.g., design transfer, validation of non-product software, and rational for sample sizes in design verification and validation).

    (b) we started early based on available draft texts of the standard, free webinars, and a paid one day training for our QMS manager. 

    1. Our Notified Body does not ask us trick(y) questions and does not have a "gotcha" attitude toward us.
       
    2. For some time now, TüV does not provide their checklists anymore. Yet, you can easily find sample checklists from other sources (see the examples mentioned in the thread).
       
    3. Our biggest hurdle was understanding what was meant by risk management for the QMS processes. We found a plausible answer early on in one of the free webinars we attended, had this confirmed at the abovementioned training day for our QMS manager, and then implemented this.
       
    4. Our company size and structure facilitated the expeditious implementation of the required changes to our QMS. We could keep the number of staff involved with the transition effort (e.g., for updating the corresponding SOPs and WIs) to the minimum without the need for large working groups or committees.

    With kindest regards and best of luck with your transition !



    ------------------------------
    Ary Saaman
    Director, Regulatory Affairs
    Debiotech S.A.
    Lausanne
    Switzerland
    ------------------------------



  • 9.  RE: Tips for ISO 13485:2016 transition

    Posted 17-Oct-2017 17:59
    Hi Ary (et. al.),

    I really appreciate the discussion. I know that notified bodies (auditing organizations) are really worried about the number of organizations that need to complete the transition, but do not fear and you will get there.

    The only issue I have is this propensity to call talk about risk management of QMS processes. That is NOT the requirement. The requirement (from 4.1.2 b) is to implement risk based controls within QMS processes. If you are performing risk management on QMS processes you going much, MUCH further than meeting that requirement. Please ask better questions of your auditing organization and challenge them to get this right. Good luck...

    ------------------------------
    Regards,
    Mark Swanson, ASQ CBA, CMQ/OE, CQE MBA
    Becker MN
    United States
    ------------------------------



  • 10.  RE: Tips for ISO 13485:2016 transition

    Posted 18-Oct-2017 14:42
    ​Hello Ary,

    Can you please speak more to this?

    "Our biggest hurdle was understanding what was meant by risk management for the QMS processes. We found a plausible answer early on in one of the free webinars we attended, had this confirmed at the abovementioned training day for our QMS manager, and then implemented this."

    Do you remember where you saw the webinar or who made it? This is where I am having a lot of trouble too.  We have our Risk Mgt. set up as product based currently and we aren't sure how to implement this. 

    Thanks



    ------------------------------
    Carrie Osing
    Regulatory Affairs Manager
    Bisco, Inc.
    Schaumburg IL
    United States
    ------------------------------



  • 11.  RE: Tips for ISO 13485:2016 transition

    Posted 18-Oct-2017 15:24
    Hi Carrie,

    I do present RM issues involving processes. You may contact me directly offline.  

    Thank you.

    s/ David
    ______________________________________________
    Dr. David Lim, Ph.D., RAC, ASQ-CQA 
    REGULATORY DOCTOR
    Phone (Toll-Free): 1-(800) 321-8567

    NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.







  • 12.  RE: Tips for ISO 13485:2016 transition

    Posted 20-Oct-2017 10:44
    (I regret I could not find the time to reply any earlier).

     

    Thank you all, in particular Carrie and Mark, for your contributions to this thread. It seems we hit an interesting point of discussion, where we need to do "the right thing" when it comes to our QMS, i.e., not too little (compliance is not an option, it is mandatory) and not too much either (no waste of our valuable resources). 

    Regarding the (free) webinar that mentioned the notion of "risk management for the QMS processes", I believe this was a November 2016 webinar by Pilgrim entitled "ISO 13485:2016 – Will it be a marathon or a sprint ?". Risk relates to not meeting regulatory requirements. One of the presenters was Mr. Dan O'Leary, who is a regular contributor to this RAPS Regulatory Forum, and if he reads this thread he could maybe speak to this. We have a copy of the webinar slides on file and we are willing to share it with you (please, provide your e-mail address and we will send them to you). 

    The one day training that confirmed our intent to implement a form of (regulatory) Risk Management for the QMS processes was given by a Notified Body other than our own Notified Body (which is TüV SüD Product Service of Munich, Germany). We specifically asked the trainer whether we were on the right track with this and her answer was affirmative. 

    As a side note : of course and like most of you, within our QMS we had already implemented many risk management activities as per ISO 14971, including performing risk assessments of our manufacturing processes, and the same for risk-based decision making (which already goes back to the preamble of 21 CFR 820 of 1996).

     

    To further the discussion and to arrive at the "right" understanding of the intent of ISO 13485:2016, clause 4.1.2b, may I recommend that you have a look at : 

    • ISO 13485:2016, clause 4.1.2b (of course) – it talks about "a risk based approach to the control of the appropriate processes needed for the quality management system" 
    • ISO 13485:2016, clause 0.2 "where the term "risk" is used …. or meeting applicable regulatory requirements" "the term "regulatory requirements" is limited to requirements for the quality management system and the safety and performance of the medical device". 
    • Guidance provided by ISO in their Handbook entitled "ISO 13485:2016 Medical devices – A practical guide", pp. 31-38. This Handbook was issued a few weeks ago, well after we started our transition to rev2016 and a few weeks after we already successfully passed our "upgrade audit". On p. 35 it is written "In addition, 4.1.2 requires that the risk-based approach is also applied to and within the appropriate processes in your QMS. " Note that at least the wording is somewhat different from the wording in the norm.

    Thereafter, please share in this forum how you feel about the notion (or not) of managing regulatory risks of your QMS processes.

    To be continued … Have a great weekend and with kindest regards,



    ------------------------------
    Ary Saaman
    Director, Regulatory Affairs
    Debiotech S.A.
    Lausanne
    Switzerland
    ------------------------------



  • 13.  RE: Tips for ISO 13485:2016 transition

    Posted 20-Oct-2017 17:19
    Ary,

    Your points are valid!

    Sometimes, we need to apply our common sense to better understand a subject/topic. 

    My common sense tells me that we should try to control what we can control.  We shouldn't try to control what we can't control. In other words, we can control processes leading to results (e.g., product). When processes are not in good control, we know what happens! 

    I've seen some firms' QMS implementation is great or OK with some room for improvement.  Some other firms have much gaps to fill in. 

    In a recent case, a firm had many certificates hanging over the wall around the hallway, looking just great! I provided serious advice on process deviations.  They were unwilling to change but have rather chosen to cease operation!

    Risk management doesn't require adequate QMS. But to claim to have implemented an adequate (or holistic) QMS, risk management is an integral part of the QMS. 

    Ironically speaking, the firm spent so much time and efforts trying to obtain EN ISO 13485:#### (they've got it), but failed to identify, estimate, evaluate, mitigate and control all potential risks for regulatory requirements, quality and device performance, resulting in making serious mistakes (e.g., in particular, ignoring serious risks when processes are deviated). 

    To prevent this similar incident from happening on a global basis, I now provide training programs for awareness and/or motivating employees/others!

    Thank you.

    s/ David
    ______________________________________________
    Dr. David Lim, Ph.D., RAC, ASQ-CQA 
    REGULATORY DOCTOR
    Phone (Toll-Free): 1-(800) 321-8567

    NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.